07 Oct 2026
Transmission of Annual Report for the Year Ended June 30, 2026 Macter International Limited transmitted its Annual Financial Statements for the year ended June 30, 2026, to the Pakistan Stock Exchange. Financials 07 Oct 2026
Notice of Annual General Meeting Macter International Limited has issued its Notice of Annual General Meeting (AGM) to be held on October 28, 2026. Key agenda items include adopting financial statements for the year ended June 30, 2026, appointing auditors, electing directors, and a special resolution for the sub-division of the company's ordinary shares from a face value of Rs. 10 to Rs. 2 each. Meetings 25 Sep 2026
Material Information Macter International Limited has announced the successful commercial launch of Hepanox (Enoxaparin Sodium) Pre-Filled Syringe (PFS), a low molecular weight heparin anticoagulant. This new product launch represents a significant milestone in expanding the company's biopharmaceuticals portfolio and strengthens its market presence in the anticoagulant therapeutic segment. Material 23 Sep 2026
Material Information Macter International Limited announced that its Board of Directors has proposed a subdivision of the company's shares, reducing the face value from Rs. 10 to Rs. 2 per share, subject to shareholder and regulatory approvals. Shareholders will receive 5 shares of Rs. 2 each for every 1 share of Rs. 10 held, restructuring the share capital from 45,811,018 shares to 229,055,090 shares without changing the total paid-up capital. Material 23 Sep 2026
Financial Results for the Year Ended June 30, 2026 Macter International Limited announced its financial results for the year ended June 30, 2026, reporting a consolidated profit after tax of PKR 675.17 million (EPS: PKR 14.83) compared to PKR 786.93 million (EPS: PKR 16.95) in the prior year. The Board of Directors has recommended nil dividend, bonus, or right shares for the year. Financials 22 Sep 2026
Board Meeting In Progress Macter International Limited announced that its board meeting scheduled for September 22, 2026, to consider annual financial results for the year ended June 30, 2026, is currently in progress. The decisions made by the board will be communicated to the exchange upon conclusion. Meetings 15 Sep 2026
Board Meeting Macter International Limited has announced that a meeting of its Board of Directors will be held on September 22, 2026, to consider the annual financial results for the period ended June 30, 2026, and potential entitlements. A closed period is in effect from September 15 to September 22, 2026. Meetings 07 Sep 2026
Change of Chief Financial Officer Macter International Limited has announced a change in its leadership, with Syed Naveed Rizvi ceasing to be the Chief Financial Officer effective September 4, 2026, and Mr. Shafiq Afzal Khan being appointed as the new Chief Financial Officer. Material 07 Aug 2026
Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations Macter International Limited reported insider share transfers involving two executive directors under PSX Regulation 5.6.4, consisting of a gift out of 150,000 shares by Asif Misbah and a gift in of 150,000 shares by Swaleh Misbah Khan. Insiders 06 Aug 2026
Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations Macter International Limited disclosed an insider share transaction under PSX Regulation 5.6.4, reporting that Executive Director Swaleh Misbah Khan gifted out 775,000 shares through CDC on August 4, 2026. Insiders 30 Jul 2026
Notice regarding Unclaimed Dividend / Shares under section 244 of the Companies Act, 2017 Macter International Limited has issued a final notice regarding unclaimed dividends and shares remaining unpaid for a period of three years, inviting shareholders to lodge claims within 90 days before the unclaimed amounts are deposited with the Federal Government under the Companies Act, 2017. OTHERS 24 Jul 2026
Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations Asif Misbah, an Executive Director of Macter International Limited, sold 475,000 shares of the company at a rate of 400.00 per share on July 24, 2026. Insiders 22 Jun 2026
Approval of Annual Budget for the Financial Year 2026-27 Macter International Limited has announced that its Board of Directors approved the company's annual budget for the financial year 2026-27 during a meeting held on June 20, 2026. OTHERS 12 Jun 2026
Board Meeting Other Than Financial Results Macter International Limited has announced a board meeting scheduled for June 20, 2026, to consider and approve the company's annual budget for the fiscal year 2026-27. A closed period for trading in company shares has been declared from June 12, 2026, to June 20, 2026. Meetings 30 Apr 2026
Transmission of Quarterly Report for the Period Ended March 31, 2026 Financials 27 Apr 2026
Financial Results for the Quarter Ended March 31, 2026 Financials 17 Apr 2026
Board Meeting Macter International Limited has announced that a meeting of its Board of Directors will be held on April 25, 2026, to consider quarterly financial results and potential entitlements. A closed period is in effect from April 17 to April 25, 2026. Meetings 17 Apr 2026
Board Meeting Macter International Limited has announced that a meeting of its Board of Directors will be held on April 25, 2026, to consider the quarterly financial results for the period ended March 31, 2026, and potential entitlements. A closed period has been declared from April 17, 2026, to April 25, 2026. Meetings 17 Mar 2026
Presentation of Corporate Briefing Session Briefings 13 Mar 2026
Rescheduled Corporate Briefing Session of Macter International Limited Briefings 
